Novartis Resumes Merger Search; Talks Up Schering, Ups Stake In Roche
Executive Summary
Novartis is resuming its search for a merger partner, CEO Daniel Vasella indicated during the company's 2003 results conference Jan. 22 in Zurich
You may also be interested in...
M&A Will Accelerate In European Markets, Slow Down In U.S. – Schering CEO
The Rx drug industry can expect to see much more merger activity among European companies, while consolidation in the U.S. essentially has tapered off, Schering-Plough CEO Fred Hassan said
Roche Pipeline Potency Validates No-Merger Stance, Company Says
Roche has the third largest pipeline of new molecular entities in development in the drug industry, the company maintained during an R&D day in New York City May 6
Roche Pipeline Potency Validates No-Merger Stance, Company Says
Roche has the third largest pipeline of new molecular entities in development in the drug industry, the company maintained during an R&D day in New York City May 6